Last €2.70 EUR
Change Today 0.00 / 0.00%
Volume 0.0
As of 2:16 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David C. Goldberg

Vice President of Corporate Development, Enzo Biochem Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

57$296,802
As of Fiscal Year 2014

Background*

Mr. David C. Goldberg serves as Vice President of Corporate Development at Enzo Biochem Inc. Mr. Goldberg serves as General Manager of Enzo Clinical Labs, Inc. Mr. Goldberg served as Senior Vice President of Enzo Clinical Labs and Interim General Manager of Enzo Clinical Labs at Enzo Biochem Inc. Mr. Goldberg served as Vice President of Business Development of Enzo Biochem Inc. since 1995. Prior to Enzo Biochem Inc. in 1985, he was employed at DuPont NEN Products and ...

Read Full Background

Corporate Headquarters*

527 Madison Avenue
New York, New York 10022

United States

Phone: 212-583-0100
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA
New York University
MS
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Salary$215,000
Total Annual Compensation$215,000

Stock Options*

All Other Compensation$29,460
Exercisable Options10,000
Unexercisable Options56,884
Total Number of Options66,884

Total Compensation*

Total Annual Cash Compensation$264,460
Total Short Term Compensation$215,000
Other Long Term Compensation$29,460
Total Calculated Compensation$296,802
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EZB:GR €2.70 EUR 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Raymond C. Kubacki Jr.Chairman, Chief Executive Officer and President
Psychemedics Corp.
$500.4K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Ivan D. Trifunovich Ph.D.Chairman of The Board, Chief Executive Officer and President
WaferGen Bio-systems, Inc.
$720.0K
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
$384.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZO BIOCHEM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.